Trial intelligence / Profile preview

Bi-Weekly Docetaxel + HDFL for Advanced Gastric Cancer

NCT00155883Phase 2Terminated

Sponsor
National Taiwan University Hospital
Start
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in gastric cancer (GC), sponsored by National Taiwan University Hospital. Started Jun 2004; status: terminated.

02

Drugs

docetaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00155883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00155883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call